NDC 80425-0273-01 - DICLOENAC SODIUM and MISOPROSTOL DR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0273
- Requested NDC
- 80425-0273-01
- Package NDCs from labels
- 80425-0273-1, 80425-0273-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-02-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DICLOENAC SODIUM and MISOPROSTOL DR - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-02-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0273-1 | DICLOENAC SODIUM and MISOPROSTOLDR | 60 in 1 BOTTLE | TABLET | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0273 | DICLOENAC SODIUM AND MISOPROSTOL DR (DICLOENAC SODIUM AND MISOPROSTOL) TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 1 package rows | 20240224_f4d8c198-63e1-3109-e053-2995a90acad9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0273-1 | EA - Each | 80425-0273 | 3eacc955-b88d-467e-9b61-60fb0611f428 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| arthritis pain reliever | DICLOFENAC SODIUM | HyVee Inc | bc74d53d-4142-4391-935b-61b7e353bd65 | 2026-04-30 | Warnings | QTG126297Q |
| Diclofenac Sodium D/R | DICLOFENAC SODIUM D/R | DirectRx | 50886f90-8cd0-4d38-e063-6294a90a44e4 | 2026-04-28 | Warnings, Adverse reactions | QTG126297Q |
| TOPCARE ARTHRITIS PAIN RELIEVER | DICLOFENAC SODIUM | Topco Associates LLC | 1d6c4c38-3739-4d58-9811-bac09fcbfadb | 2026-04-24 | Warnings | QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | REMEDYREPACK INC. | 7e940ce5-0f82-4d07-b507-c644481879c1 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Walgreens | 33a37e3d-0463-428c-9169-240eeb77af2b | 2026-04-21 | Warnings | QTG126297Q |
| EQUATE ARTHRITIS PAIN | DICLOFENAC SODIUM | WALMART INC. | d05b5f82-8772-4e01-8eb3-6fa6042f5661 | 2026-04-20 | Warnings | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | b28e4a68-f396-4c1a-ba38-6a972906b4d0 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | ASCLEMED USA INC. | fd94964b-167b-41b7-a612-8febe9ae0511 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | REMEDYREPACK INC. | 96f8c42c-db34-43b0-a891-33dd8e39e74f | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium Delayed Release | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | e947653c-6789-4c15-82c9-4b1402f6d6ac | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | ed1b5ec7-2812-4a81-90d1-953baa0b0ec8 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Aurolife Pharma LLC | dfb7afdf-5c05-4487-9044-936e151e5ba6 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 5d0a4b41-afbf-45e7-bb1c-587d72314ee0 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | 15b280a1-4964-4636-833b-3db44044d289 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC | Preferred Pharmaceuticals Inc. | 937e9ba5-cdad-4e72-a77a-bad699e1b236 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals, Inc. | 4a3549e0-1e2d-42bf-b82c-1e62837ba2e4 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Preferred Pharmaceuticals Inc. | e042e64c-5f18-4483-bcbd-dfd9b08a81cf | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL GEL, 1%, | Preferred Pharmaceuticals, Inc. | aee20924-79ab-400e-b9b6-418978914654 | 2026-04-02 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| arthritis pain relieving | DICLOFENAC SODIUM | Walgreen Company | 0da5d1d0-d8a4-4509-a098-e9c36d282474 | 2026-03-31 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | REMEDYREPACK INC. | d349d286-b462-4f8f-aa39-6173653175d6 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.